D-Index & Metrics Best Publications
Immunology
UK
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 122 Citations 50,440 435 World Ranking 108 National Ranking 7
Medicine D-index 125 Citations 54,701 483 World Ranking 1233 National Ranking 124

Research.com Recognitions

Awards & Achievements

2022 - Research.com Immunology in United Kingdom Leader Award

1990 - Fellow of the Royal Society, United Kingdom

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Gene
  • Antibody

His primary areas of investigation include Immunology, Antibody, Transplantation, Monoclonal antibody and Antigen. T cell, Immune system, Immune tolerance, Immunotherapy and Immunosuppression are the core of his Immunology study. His Antibody study combines topics from a wide range of disciplines, such as Molecular biology, In vivo and Virology.

His work deals with themes such as CD8 and Bone marrow, which intersect with Transplantation. His Monoclonal antibody research incorporates elements of T lymphocyte, Autoimmune disease, Immunogenicity, Pathology and Immunoglobulin E. He interconnects Immunity and Effector in the investigation of issues within Antigen.

His most cited work include:

  • Reshaping human antibodies for therapy. (2938 citations)
  • Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. (956 citations)
  • "Infectious" transplantation tolerance (814 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Immunology, Monoclonal antibody, Transplantation, Antibody and Antigen. Immune system, T cell, Immune tolerance, Immunosuppression and Bone marrow are the subjects of his Immunology studies. His T cell study combines topics in areas such as Cytotoxic T cell and Cell biology.

His Monoclonal antibody research is multidisciplinary, relying on both T lymphocyte, CD8, In vivo and Immunotherapy. The Antibody study combines topics in areas such as CD3 and Virology. His study in Antigen is interdisciplinary in nature, drawing from both Molecular biology and In vitro.

He most often published in these fields:

  • Immunology (57.40%)
  • Monoclonal antibody (28.85%)
  • Transplantation (25.50%)

What were the highlights of his more recent work (between 2007-2021)?

  • Immunology (57.40%)
  • Immune system (16.03%)
  • FOXP3 (5.80%)

In recent papers he was focusing on the following fields of study:

Immunology, Immune system, FOXP3, Cell biology and Transplantation are his primary areas of study. His research related to Immune tolerance, Antigen, Monoclonal antibody, Antibody and Immunosuppression might be considered part of Immunology. His Monoclonal antibody study deals with Virology intersecting with Transgene.

His biological study spans a wide range of topics, including Cancer research, Regulatory T cell, IL-2 receptor, Cytokine and CD8. Herman Waldmann has included themes like T cell, T cell differentiation and Tolerance induction in his Cell biology study. Transplantation is a subfield of Surgery that Herman Waldmann explores.

Between 2007 and 2021, his most popular works were:

  • Plasticity of Foxp3+ T Cells Reflects Promiscuous Foxp3 Expression in Conventional T Cells but Not Reprogramming of Regulatory T Cells (454 citations)
  • Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity (435 citations)
  • The plasticity and stability of regulatory T cells. (341 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Gene
  • Internal medicine

His main research concerns Immunology, Cell biology, FOXP3, T cell and Immune system. The concepts of his Immunology study are interwoven with issues in In vivo and Transplantation. His Cell biology research integrates issues from Regulatory T cell, Downregulation and upregulation and CD8.

His studies in FOXP3 integrate themes in fields like IL-2 receptor, Cellular differentiation, Cytokine, Antigen and Receptor. His studies deal with areas such as Interleukin 2 and Biochemistry as well as T cell. His Immune system study incorporates themes from Proinflammatory cytokine and Regulation of gene expression.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Reshaping human antibodies for therapy.

Lutz Riechmann;Michael Clark;Herman Waldmann;Greg Winter.
Nature (1988)

3039 Citations

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

Bart Keymeulen;Evy Vandemeulebroucke;Anette G. Ziegler;Chantal Mathieu.
The New England Journal of Medicine (2005)

1201 Citations

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

S P Cobbold;A Jayasuriya;A Nash;T D Prospero.
Nature (1984)

1072 Citations

"Infectious" transplantation tolerance

Shixin Qin;Stephen P. Cobbold;Heather Pope;James Elliott.
Science (1993)

995 Citations

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

M Brüggemann;G T Williams;C I Bindon;M R Clark.
Journal of Experimental Medicine (1987)

826 Citations

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

G. Hale;M.R. Clark;R. Marcus;G. Winter.
The Lancet (1988)

703 Citations

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.

A Davies;D L Simmons;G Hale;R A Harrison.
Journal of Experimental Medicine (1989)

688 Citations

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).

Jeanette Lundin;Eva Kimby;Magnus Björkholm;Per-Anders Broliden.
Blood (2002)

668 Citations

Identification of regulatory T cells in tolerated allografts

Luis Graca;Stephen P. Cobbold;Herman Waldmann.
Journal of Experimental Medicine (2002)

666 Citations

The window of therapeutic opportunity in multiple sclerosis : Evidence from monoclonal antibody therapy

A. J. Coles;A. Cox;E. Le Page;J. Jones.
Journal of Neurology (2006)

648 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Herman Waldmann

Kathryn J. Wood

Kathryn J. Wood

University of Oxford

Publications: 164

Rainer Storb

Rainer Storb

Fred Hutchinson Cancer Research Center

Publications: 96

Lucienne Chatenoud

Lucienne Chatenoud

Necker-Enfants Malades Hospital

Publications: 95

Rolf M. Zinkernagel

Rolf M. Zinkernagel

University of Zurich

Publications: 95

Jeffrey A. Bluestone

Jeffrey A. Bluestone

University of California, San Francisco

Publications: 93

Robert I. Lechler

Robert I. Lechler

King's College London

Publications: 88

Hans Hengartner

Hans Hengartner

University of Zurich

Publications: 82

Shimon Sakaguchi

Shimon Sakaguchi

Osaka University

Publications: 78

Mohamed H. Sayegh

Mohamed H. Sayegh

Brigham and Women's Hospital

Publications: 78

Kevan C. Herold

Kevan C. Herold

Yale University

Publications: 74

John M. Goldman

John M. Goldman

Imperial College London

Publications: 66

Brenda M. Sandmaier

Brenda M. Sandmaier

Fred Hutchinson Cancer Research Center

Publications: 64

Karl S. Peggs

Karl S. Peggs

University College London

Publications: 63

Megan Sykes

Megan Sykes

Columbia University

Publications: 62

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 62

Giovanna Lombardi

Giovanna Lombardi

King's College London

Publications: 59

Trending Scientists

Dana S. Nau

Dana S. Nau

University of Maryland, College Park

David Kazhdan

David Kazhdan

Hebrew University of Jerusalem

Shiyu Chang

Shiyu Chang

University of California, Santa Barbara

David H. Owens

David H. Owens

University of Sheffield

Nicolas G Green

Nicolas G Green

University of Southampton

Suman L. Jain

Suman L. Jain

Indian Institute of Petroleum

Moo Hwan Cho

Moo Hwan Cho

Yeungnam University

A.L. Greer

A.L. Greer

University of Cambridge

Sven Jonasson

Sven Jonasson

University of Copenhagen

Frank R. Moore

Frank R. Moore

University of Southern Mississippi

Scott A. Beatson

Scott A. Beatson

University of Queensland

George Harauz

George Harauz

University of Guelph

Yoshinori Moriyama

Yoshinori Moriyama

Okayama University

Toshihisa Komori

Toshihisa Komori

Nagasaki University

Robert J. McDonald

Robert J. McDonald

University of Lethbridge

Susan K. Fried

Susan K. Fried

Icahn School of Medicine at Mount Sinai

Something went wrong. Please try again later.